Become A Featured Company

What is the Marijuana Justice Act?

Kelly Weimert

March 13th, 2019

Policy

The Marijuana Justice Act was first introduced by 2020 presidential hopeful, Senator Cory Booker (D-NJ), in August of 2017. The bill is designed to federally decriminalize marijuana while promoting restorative justice for populations that are disproportionately affected by cannabis prohibition, such as people of color and low-income communities.

Changes That the Marijuana Justice Act Would Enact

The Marijuana Justice Act would make several important changes if passed into law. Topmost among those changes is that it would remove marijuana from the Controlled Substances Act, which would essentially end the federal government’s prohibition of cannabis.

In addition, the act would cut all federal funding for state law enforcement and prison construction in states where low-income and minority populations are being disproportionately arrested and incarcerated for marijuana offenses. It would also allow entities to sue any state that disproportionately arrests and incarcerates marginalized communities for these offenses.

With respect to those who are already incarcerated for marijuana offenses, the bill would provide a process of expungement at the federal level as well as federal resentencing processes for marijuana offenses. Those who are currently incarcerated for marijuana offenses would likely see their case expunged or sentence reduced. Moreover, the bill would prevent anyone with a minor marijuana offense from being deported for it.

In addition to taking punitive action on states, prisons, and law enforcement agencies that disproportionately arrest marginalized communities for marijuana, the bill would create a “Community Reinvestment Fund,” which would allocate funds to rebuild the communities that have been harmed by marijuana prohibition and incarceration.

Booker said of the bill: “The War on Drugs has not been a war on drugs, it’s been a war on people, and disproportionately people of color and low-income individuals. The Marijuana Justice Act seeks to reverse decades of this unfair, unjust, and failed policy by removing marijuana from the list of controlled substances and making it legal at the federal level.”

Impact of Federal Legalization

Federal legalization will minimize several pressing problems and injustices in addition to making access to cannabis easier. For example, nearly half of all drug arrests are for simple marijuana position, and between 2001 and 2010, there were over 8 million marijuana arrests in the United States. A marijuana arrest can cause difficulty with securing employment, housing, and federal financial aid.

Legalizing marijuana at the federal level could significantly mitigate the opioid crisis, as research suggests that cannabis is an effective treatment for pain with a better safety profile than opiates and less risk for dependence. This crisis is leading to addiction, hospitalization, and death for a growing population. Legal access to marijuana has been associated with a 23% reduction in opioid dependence and abuse-related hospitalizations, as well as 15% fewer opioid treatment admissions.

Federal legalization also has the potential to significantly improve communities. Colorado, for example, is allocating marijuana revenues for social good, distributing $230 million to the Colorado Department of Education between 2015 and 2017. Meanwhile, Washington state dedicates 25% of marijuana profits to substance use disorder treatment, education, and prevention and 55% of cannabis tax revenue to fund basic health plans.

Congressional Support for the Marijuana Justice Act

The Marijuana Justice Act, which was initially cosponsored by Senators Barbara Lee (D-CA) and Ro Khanna (D-CA), in addition to Booker, is garnering increased support from Congress.

Its current cosponsors in the Senate include Senators Ron Wyden (D-OR), Kirsten Gillibrand (D-NY), Bernie Sanders (I-VT), Kamala Harris (D-CA), Jeff Merkley (D-OR), Elizabeth Warren (D-MA), and Michael Bennet (D-CO).

The bill also boasts a laundry list of sponsors from the House of Representatives:

  • Rep. Barbara Lee (D-CA-13)*
  • Rep. Ro Khanna (D-CA-17)*
  • Rep. Sheila Jackson Lee (D-TX-18)*
  • Rep. Steve Cohen (D-TN-9)*
  • Rep. Eleanor Holmes Norton (D-DC-At Large)*
  • Rep. Bobby L. Rush (D-IL-1)*
  • Rep. Earl Blumenauer (D-OR-3)*
  • Rep. Danny Davis (D-IL-7)*
  • Rep. Jared Polis (D-CO-2)*
  • Rep. Hakeem S. Jeffries (D-NY-8)*
  • Rep. Pramila Jayapal (D-WA-7)*
  • Rep. Yvette D. Clarke (D-NY-9)*
  • Rep. Marcia L. Fudge (D-OH-11)*
  • Rep. Donald M. Payne Jr. (D-NJ-10)*
  • Rep. Bennie G. Thompson (D-MS-2)*
  • Rep. Frederica Wilson (D-FL-24)*
  • Rep. Mark Pocan (D-WI-2)*
  • Rep. Tulsi Gabbard (D-HI-2)*
  • Rep. Jamie Raskin (D-MD-8)*
  • Rep. Raul M. Grijalva (D-AZ-3)
  • Rep. Jared Huffman (D-CA-2)
  • Rep. Jerry McNerney (D-CA-9)
  • Rep. Luis J. Correa (D-CA-46)
  • Rep. Joseph Crowley (D-NY-14)
  • Rep. Donald S. Beyer Jr. (D-VA-8)
  • Rep. Carolyn B. Maloney (D-NY-12)
  • Rep. Alan S. Lowenthal (D-CA-47)
  • Rep. Gregory Meeks (D-NY-5)
  • Rep. Ruben J. Kihuen (D-NV-4)
  • Rep. Henry “Hank” C. Johnson Jr. (D-GA-4)
  • Rep. Wm. Lacy Clay (D-MO-1)
  • Rep. Karen Bass (D-CA-37)
  • Rep. Alcee L. Hastings (D-FL-20)
  • Rep. Emanuel Cleaver (D-MO-5)
  • Rep. Cedric l. Richmond (D-LA-2)Rep. Eddie Bernice Johnson (D-TX-30)
  • Rep. Janice Schakowsky D. (D-IL-9)
  • Rep. Anthony G. Brown (D-MD-4)
  • Rep. John Lewis (D-GA-5)
  • Rep. Tim Ryan (D-OH-13)
  • Rep. Bonnie Watson Coleman (D-NJ-12)
  • Rep. Luis V. Gutierrez (D-IL-4)

*cosponsored initial bill

While the bill has been largely stagnant since its 2017 inception, given its widespread congressional support, including several presidential hopefuls, the 2020 election is likely to bring it back to the forefront of federal policy conversations.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Kelly Weimert

Kelly is a full-time freelance writer based in Austin, TX. A happy hybrid of geek and hippie, when she's not nestled into her couch crankin' out crafty prose with her miscreant Chihuahua, you can find her frolicking outside to keep her sanity in check.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading